Chitosan Phonophresis on Cervical IN Smartphone Addicted Users
Effect of Chitosan Phonophresis on Cervical Pain and Disability in Smartphone Addicted Users
1 other identifier
interventional
30
1 country
1
Brief Summary
A phonophoresis-based drug delivery system is a synchronous approach to improve local drug penetration in neuromuscular diseases associated with neuronal damage, excruciating pain, and local inflammation. Chitosan, a semi-synthetic material, is obtained by partial deacetylation of chitin amines, resulting in copolymers of N-acetylglucosamine and N-glucosamine. Its use has been explored in various biomaterial and medical applications. Chitosan has emerged as a cost-effective, biocompatible, and biodegradable material with many desirable biological properties, improvement of homeostasis and antiviral potential. Chitosan was found to suppress pro-inflammatory cytokines and decreased peripheral nerve edema, the polycationic nature of chitosan allows it to absorb protons, which reduces inflammation and provides an analgesic effect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedFirst Posted
Study publicly available on registry
July 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2024
CompletedJuly 9, 2024
July 1, 2024
3 months
July 1, 2024
July 1, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Smartphone Addiction Scale-Short Version (SAS-SV)
SAS-SV was psychometrically robust in measuring the severity of smartphone addiction
four weeks
The visual analogue scale
was utilized to evaluate pre- and post-treatment neck pain
four weeks
Neck disability index
assess how neck pain and other symptoms manifested during various functional activities. Ndi had been reported as a reliable (Cronbach's alpha: 0.89) and valid instrument to evaluate self-rated disability in patients with neck pain
four weeks
Secondary Outcomes (1)
Cervical ROM
four weeks
Study Arms (2)
study group
EXPERIMENTALChitosan Phonophresis intervention
control group
EXPERIMENTALthe selected exercise program
Interventions
selected neck exercise and electrotherapy on cervical region
Eligibility Criteria
You may qualify if:
- Their age will be ranged from 16-18 years
- body mass index will be 26.58 kg/m2.
- used a smart phone for more than 1 year for at least 2 hours per day
- complaining of neck pain after using a smart phone, addiction to smart phone in accordance with the smart phone addiction scale (SAS)
You may not qualify if:
- any previous head and neck injuries or surgeries
- any congenital abnormalities or symptomatic deformity in either the cervical or the lumbar spine
- any uncorrected visual or auditory problems, dizziness, vertigo and headache
- any systematic diseases, any addiction to alcohol, any additive drugs and sedatives within 48 hours previous to tests
- body mass index of subjects over25 kg/m2.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lama S Mahmoud
Al Jīzah, Select State, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lama Saad El-Din Mahmoud
Study Record Dates
First Submitted
July 1, 2024
First Posted
July 9, 2024
Study Start
July 1, 2024
Primary Completion
September 30, 2024
Study Completion
October 15, 2024
Last Updated
July 9, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share